FDA and Pharmanex clash over dietary supplement.
D000329:Advertising; D000924:Anticholesteremic Agents; D017277:Drug Approval; D004345:Drug Industry; D005527:Food, Fortified / Q000592:standards*; D008148:Lovastatin; D008516:Medicine, Chinese Traditional; D012275:Oryza; D008517:Phytotherapy; D014481:United States; D014486:United States Food and Drug Administration
D000924:Anticholesteremic Agents; D008148:Lovastatin